<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_metabolic" title="Identifying Metabolic Perturbations and Toxic Effects of Rac-Metalaxyl and Metalaxyl-M in Mice Using Integrative NMR and UPLC-MS/MS Based Metabolomics" shortTitle="metabolic" author="Ping Zhang, Sheng Wang, Yuhan He, Yangyang Xu, Dongmei Shi, Furong Yang, Weizhong Yu, Wentao Zhu, Lin He" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1422-0067/20/21/5457/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
3.	LS	3.
Discussion	NN	discussion
</s>
</head>
<p>
<s type="sub">
Urine	NN	urine
is	VBZ	be
a	DT	a
vital	JJ	vital
biofluid	NN	biofluid
in	IN	in
mammals	NNS	mammal
and	CC	and
could	MD	could
be	VB	be
easily	RB	easily
collected	VBN	collect
in	IN	in
a	DT	a
noninvasive	JJ	noninvasive
manner	NN	manner
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
the	DT	the
metabolites	NNS	metabolite
components	NNS	component
and	CC	and
concentrations	NNS	concentration
in	IN	in
urine	NN	urine
are	VBP	be
good	JJ	good
indicators	NNS	indicator
of	IN	of
metabolic	JJ	metabolic
fluctuations	NNS	fluctuation
.	.	.
</s>
<s type="sub">
Comparison	NN	comparison
of	IN	of
metabolite	NN	metabolite
profiles	NNS	profile
between	IN	between
the	DT	the
treatment	NN	treatment
group	NN	group
and	CC	and
the	DT	the
control	NN	control
group	NN	group
could	MD	could
obtain	VB	obtain
metabolic	JJ	metabolic
changes	NNS	change
and	CC	and
reveal	VB	reveal
adverse	JJ	adverse
effects	NNS	effect
mechanism	NN	mechanism
of	IN	of
stressor	NN	stressor
.	.	.
</s>
<s type="decl">
In	IN	in
this	DT	this
study	NN	study
,	,	,
1H-NMR	NNP	1h-nmr
and	CC	and
UPLC-MS/MS	NNP	UPLC-MS/MS
based	VBN	base
metabolomics	NN	metabolomics
were	VBD	be
employed	VBN	employ
to	TO	to
investigate	VB	investigate
the	DT	the
metabolic	JJ	metabolic
perturbations	NNS	perturbation
after	IN	after
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	JJ	metalaxyl-M
exposure	NN	exposure
.	.	.
</s>
<s type="decl">
The	DT	the
results	NNS	result
showed	VBD	show
that	IN	that
both	DT	both
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	NN	metalaxyl-M
induced	VBD	induce
systematic	JJ	systematic
metabolic	JJ	metabolic
changes	NNS	change
in	IN	in
urine	NN	urine
and	CC	and
serum	NN	serum
.	.	.
</s>
<s type="decl">
<hi rend="italic">
Rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	NNP	metalaxyl-M
induced	VBD	induce
liver	NN	liver
damages	NNS	damage
and	CC	and
metabolic	JJ	metabolic
pathway	NN	pathway
changes	NNS	change
including	VBG	include
glycine	NN	glycine
,	,	,
serine	NN	serine
,	,	,
and	CC	and
threonine	NN	threonine
metabolism	NN	metabolism
,	,	,
citrate	NN	citrate
cycle	NN	cycle
(	-LRB-	(
TCA	NNP	TCA
cycle	NN	cycle
)	-RRB-	)
,	,	,
pyruvate	NN	pyruvate
metabolism	NN	metabolism
,	,	,
glycolysis	NN	glycolysis
or	CC	or
gluconeogenesis	NN	gluconeogenesis
,	,	,
glycerophospholipid	NN	glycerophospholipid
metabolism	NN	metabolism
,	,	,
and	CC	and
glyoxylate	NN	glyoxylate
and	CC	and
dicarboxylate	NN	dicarboxylate
metabolism	NN	metabolism
.	.	.
</s>
<s type="decl">
These	DT	this
pathways	NNS	pathway
are	VBP	be
highly	RB	highly
related	VBN	relate
to	IN	to
energy	NN	energy
metabolism	NN	metabolism
,	,	,
lipid	NN	lipid
metabolism	NN	metabolism
,	,	,
amino	NN	amino
acids	NNS	acid
metabolism	NN	metabolism
,	,	,
microbial	JJ	microbial
metabolism	NN	metabolism
,	,	,
and	CC	and
tryptophan	NN	tryptophan
metabolism	NN	metabolism
.	.	.
</s>
</p>
<head>
<s type="frag">
3.1.	CD	3.1.
Body	NN	body
Weight	NN	weight
Changes	NNS	change
and	CC	and
Liver	NN	liver
Damage	NN	damage
</s>
</head>
<p>
<s type="decl">
Only	RB	only
one	CD	one
mouse	NN	mouse
was	VBD	be
dead	JJ	dead
in	IN	in
the	DT	the
60	CD	60
mg/kg	NN	mg/kg
metalaxyl-M	NN	metalaxyl-M
treatment	NN	treatment
group	NN	group
during	IN	during
the	DT	the
whole	JJ	whole
experiment	NN	experiment
.	.	.
</s>
<s type="decl">
After	IN	after
four	CD	4
weeks	NNS	week
of	IN	of
exposure	NN	exposure
,	,	,
no	DT	no
significant	JJ	significant
changes	NNS	change
in	IN	in
body	NN	body
weight	NN	weight
were	VBD	be
observed	VBN	observe
between	IN	between
the	DT	the
control	NN	control
and	CC	and
treatment	NN	treatment
groups	NNS	group
after	IN	after
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	JJ	metalaxyl-M
exposure	NN	exposure
.	.	.
</s>
<s type="decl">
Histopathology	NN	histopathology
examination	NN	examination
showed	VBD	show
that	IN	that
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	NN	metalaxyl-M
can	MD	can
both	RB	both
induce	VB	induce
hepatocellular	JJ	hepatocellular
inflammation	NN	inflammation
,	,	,
necrosis	NN	necrosis
,	,	,
and	CC	and
vacuolation	NN	vacuolation
in	IN	in
mice	NNS	mouse
.	.	.
</s>
<s type="decl">
Such	JJ	such
results	NNS	result
suggested	VBD	suggest
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	JJ	metalaxyl-M
exposure	NN	exposure
caused	VBD	cause
liver	NN	liver
dysfunction	NN	dysfunction
in	IN	in
mice	NNS	mouse
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
metalaxyl-M	NNP	metalaxyl-M
induced	VBD	induce
greater	JJR	great
liver	NN	liver
damage	NN	damage
than	IN	than
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
at	IN	at
the	DT	the
same	JJ	same
dosage	NN	dosage
.	.	.
</s>
<s type="decl">
The	DT	the
liver	NN	liver
is	VBZ	be
a	DT	a
fundamental	JJ	fundamental
and	CC	and
essential	JJ	essential
organ	NN	organ
for	IN	for
metabolism	NN	metabolism
and	CC	and
detoxification	NN	detoxification
of	IN	of
xenobiotics	NNS	xenobiotics
with	IN	with
abundant	JJ	abundant
cytochrome	NN	cytochrome
P450	NN	P450
enzymes	NNS	enzyme
.	.	.
</s>
<s type="decl">
The	DT	the
damages	NNS	damage
of	IN	of
the	DT	the
liver	NN	liver
may	MD	may
greatly	RB	greatly
affect	VB	affect
the	DT	the
detoxification	NN	detoxification
of	IN	of
mice	NNS	mouse
.	.	.
</s>
</p>
<head>
<s type="frag">
3.2.	CD	3.2.
</s>
<s type="frag">
Energy	NN	Energy
Metabolism	NN	metabolism
</s>
</head>
<p>
<s type="decl">
Metabolites	NNS	metabolite
involved	VBN	involve
in	IN	in
energy	NN	energy
metabolism	NN	metabolism
were	VBD	be
significant	JJ	significant
changed	VBN	change
in	IN	in
mice	NNS	mouse
urine	NN	urine
after	IN	after
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	JJ	metalaxyl-M
exposure	NN	exposure
,	,	,
including	VBG	include
citrate	NN	citrate
,	,	,
succinate	NN	succinate
,	,	,
lactate	NN	lactate
,	,	,
alanine	NN	alanine
,	,	,
pyruvate	NN	pyruvate
,	,	,
and	CC	and
acetate	NN	acetate
.	.	.
</s>
<s type="decl">
These	DT	this
metabolites	NNS	metabolite
are	VBP	be
highly	RB	highly
related	VBN	relate
to	IN	to
energy	NN	energy
pathways	NNS	pathway
,	,	,
including	VBG	include
the	DT	the
TCA	NNP	TCA
cycle	NN	cycle
,	,	,
pyruvate	NN	pyruvate
metabolism	NN	metabolism
,	,	,
and	CC	and
glycolysis	NN	glycolysis
or	CC	or
gluconeogenesis	NN	gluconeogenesis
.	.	.
</s>
<s type="decl">
Citrate	NNP	Citrate
and	CC	and
succinate	NN	succinate
are	VBP	be
the	DT	the
main	JJ	main
intermediates	NNS	intermediate
in	IN	in
the	DT	the
TCA	NNP	TCA
cycle	NN	cycle
,	,	,
which	WDT	which
is	VBZ	be
mainly	RB	mainly
appeared	VBN	appear
in	IN	in
liver	NN	liver
mitochondria	NNS	mitochondria
.	.	.
</s>
<s type="decl">
Although	IN	although
other	JJ	other
factors	NNS	factor
cannot	MD	cannot
be	VB	be
excluded	VBN	exclude
,	,	,
the	DT	the
increased	VBN	increase
levels	NNS	level
of	IN	of
citrate	NN	citrate
and	CC	and
succinate	NN	succinate
in	IN	in
the	DT	the
urine	NN	urine
of	IN	of
metalaxyl-M-treated	JJ	metalaxyl-M-treated
mice	NNS	mouse
indicated	VBD	indicate
that	IN	that
metalaxyl-M	NNP	metalaxyl-M
affected	VBD	affect
the	DT	the
activity	NN	activity
of	IN	of
mitochondria	NN	mitochondria
enzymes	NNS	enzyme
involved	VBN	involve
in	IN	in
the	DT	the
TCA	NNP	TCA
cycle	NN	cycle
,	,	,
resulting	VBG	result
in	IN	in
the	DT	the
enhancement	NN	enhancement
of	IN	of
energy	NN	energy
metabolism	NN	metabolism
in	IN	in
treated	VBN	treat
mice	NNS	mouse
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
the	DT	the
decreased	VBN	decrease
level	NN	level
of	IN	of
pyruvate	NN	pyruvate
and	CC	and
increased	VBN	increase
levels	NNS	level
of	IN	of
lactate	NN	lactate
and	CC	and
alanine	NN	alanine
were	VBD	be
highly	RB	highly
related	VBN	relate
to	IN	to
pyruvate	JJ	pyruvate
metabolism	NN	metabolism
.	.	.
</s>
<s type="sub">
Pyruvate	NNP	Pyruvate
could	MD	could
be	VB	be
converted	VBN	convert
to	IN	to
acetyl-coenzyme	NNP	acetyl-coenzyme
A	NN	A
(	-LRB-	(
COA	NNP	COA
)	-RRB-	)
,	,	,
which	WDT	which
is	VBZ	be
a	DT	a
vital	JJ	vital
intermediate	NN	intermediate
in	IN	in
the	DT	the
synthesis	NN	synthesis
of	IN	of
citrate	NN	citrate
.	.	.
</s>
<s type="sub">
Lactate	NN	lactate
and	CC	and
alanine	NN	alanine
can	MD	can
also	RB	also
be	VB	be
converted	VBN	convert
to	IN	to
pyruvate	NN	pyruvate
.	.	.
</s>
<s type="sub">
Thus	RB	thus
,	,	,
the	DT	the
increased	VBN	increase
lactate	NN	lactate
and	CC	and
alanine	NN	alanine
could	MD	could
promote	VB	promote
the	DT	the
level	NN	level
of	IN	of
acetyl-COA	NN	acetyl-COA
and	CC	and
then	RB	then
up-regulate	VB	up-regulate
the	DT	the
energy	NN	energy
metabolism	NN	metabolism
.	.	.
</s>
<s type="decl">
To	TO	to
sum	VB	sum
up	RP	up
,	,	,
these	DT	this
results	NNS	result
indicated	VBD	indicate
the	DT	the
enhancement	NN	enhancement
of	IN	of
energy	NN	energy
metabolism	NN	metabolism
in	IN	in
mice	NNS	mouse
after	IN	after
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
and	CC	and
metalaxyl-M	JJ	metalaxyl-M
exposure	NN	exposure
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
the	DT	the
perturbation	NN	perturbation
degrees	NNS	degree
induced	VBN	induce
by	IN	by
metalaxy-M	NN	metalaxy-M
were	VBD	be
higher	JJR	high
than	IN	than
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxy	NN	-metalaxy
in	IN	in
energy	NN	energy
metabolism	NN	metabolism
.	.	.
</s>
</p>
<head>
<s type="frag">
3.3.	CD	3.3.
Lipid	NN	lipid
Metabolism	NN	metabolism
</s>
</head>
<p>
<s type="decl">
In	IN	in
this	DT	this
study	NN	study
,	,	,
metalaxyl-M	NN	metalaxyl-M
induced	VBD	induce
two	CD	2
lipid	JJ	lipid
metabolism	NN	metabolism
pathway	NN	pathway
fluctuations	NNS	fluctuation
including	VBG	include
glycerophospholipid	NN	glycerophospholipid
metabolism	NN	metabolism
,	,	,
glyoxylate	NN	glyoxylate
,	,	,
and	CC	and
dicarboxylate	NN	dicarboxylate
metabolism	NN	metabolism
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
no	DT	no
lipid	JJ	lipid
metabolism	NN	metabolism
pathway	NN	pathway
was	VBD	be
affected	VBN	affect
by	IN	by
<hi rend="italic">
rac	NN	rac
</hi>
-metalaxyl	NN	-metalaxyl
exposure	NN	exposure
.	.	.
</s>
<s type="decl">
According	VBG	accord
to	IN	to
metabolomics	NN	metabolomics
data	NNS	datum
,	,	,
metalaxyl-M	NN	metalaxyl-M
induced	VBD	induce
the	DT	the
increased	VBN	increase
levels	NNS	level
of	IN	of
choline	NN	choline
and	CC	and
TMAO	NN	tmao
and	CC	and
decreased	VBD	decrease
levels	NNS	level
of	IN	of
PC	NNP	PC
and	CC	and
GPC	NNP	GPC
.	.	.
</s>
<s type="decl">
<hi rend="italic">
Rac	NNP	Rac
</hi>
-metalaxyl	NN	-metalaxyl
only	RB	only
induced	VBD	induce
the	DT	the
decreased	VBN	decrease
level	NN	level
of	IN	of
GPC	NNP	GPC
.	.	.
</s>
<s type="decl">
Such	JJ	such
metabolites	NNS	metabolite
were	VBD	be
all	RB	all
related	JJ	related
to	IN	to
lipid	NN	lipid
metabolism	NN	metabolism
and	CC	and
had	VBD	have
essential	JJ	essential
effect	NN	effect
on	IN	on
cholesterol	NN	cholesterol
level	NN	level
in	IN	in
digestive	JJ	digestive
system	NN	system
.	.	.
</s>
<s type="decl">
Choline	NNP	Choline
is	VBZ	be
an	DT	a
important	JJ	important
nutrient	NN	nutrient
that	WDT	that
is	VBZ	be
required	VBN	require
for	IN	for
lipid	NN	lipid
transport	NN	transport
,	,	,
methyl-group	NN	methyl-group
metabolism	NN	metabolism
,	,	,
neurotransmitter	NN	neurotransmitter
synthesis	NN	synthesis
,	,	,
cell	NN	cell
membrane	NN	membrane
structure	NN	structure
,	,	,
and	CC	and
signaling	NN	signaling
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
choline	NN	choline
is	VBZ	be
a	DT	a
constituent	NN	constituent
of	IN	of
cell	NN	cell
membranes	NNS	membrane
and	CC	and
lipoprotein	NN	lipoprotein
phospholipids	NNS	phospholipids
,	,	,
which	WDT	which
play	VBP	play
an	DT	a
important	JJ	important
role	NN	role
in	IN	in
the	DT	the
integrity	NN	integrity
of	IN	of
cell	NN	cell
membrane	NN	membrane
and	CC	and
lipid	NN	lipid
metabolism	NN	metabolism
.	.	.
</s>
<s type="decl">
Increased	VBN	increase
choline	NN	choline
levels	NNS	level
in	IN	in
urine	NN	urine
samples	NNS	sample
suggested	VBD	suggest
the	DT	the
membrane	NN	membrane
fluidity	NN	fluidity
was	VBD	be
disrupted	VBN	disrupt
by	IN	by
metalaxyl-M	NN	metalaxyl-M
.	.	.
</s>
<s type="decl">
PC	NNP	PC
and	CC	and
GPC	NNP	GPC
are	VBP	be
known	VBN	know
to	TO	to
be	VB	be
important	JJ	important
endogenous	JJ	endogenous
metabolites	NNS	metabolite
related	VBN	relate
to	IN	to
maintenance	NN	maintenance
of	IN	of
choline	NN	choline
homeostasis	NN	homeostasis
and	CC	and
bile	NN	bile
acids	NNS	acid
excretion	NN	excretion
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
PC	NNP	PC
,	,	,
and	CC	and
GPC	NNP	GPC
are	VBP	be
not	RB	not
only	RB	only
essential	JJ	essential
components	NNS	component
of	IN	of
cell	NN	cell
membranes	NNS	membrane
,	,	,
but	CC	but
also	RB	also
protect	VBP	protect
cell	NN	cell
from	IN	from
oxidative	NN	oxidative
stress	NN	stress
and	CC	and
lipotoxicity	NN	lipotoxicity
.	.	.
</s>
<s type="sub">
The	DT	the
decreased	VBN	decrease
levels	NNS	level
of	IN	of
PC	NNP	PC
and	CC	and
GPC	NNP	GPC
may	MD	may
be	VB	be
good	JJ	good
indicators	NNS	indicator
of	IN	of
oxidative	JJ	oxidative
stress	NN	stress
and	CC	and
lipotoxicity	NN	lipotoxicity
induced	VBN	induce
by	IN	by
metalaxyl-M	NN	metalaxyl-M
.	.	.
</s>
</p>
</text>